Hilde Herrema

5.8k total citations · 2 hit papers
76 papers, 3.2k citations indexed

About

Hilde Herrema is a scholar working on Molecular Biology, Physiology and Infectious Diseases. According to data from OpenAlex, Hilde Herrema has authored 76 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 58 papers in Molecular Biology, 28 papers in Physiology and 16 papers in Infectious Diseases. Recurrent topics in Hilde Herrema's work include Gut microbiota and health (43 papers), Diet and metabolism studies (23 papers) and Clostridium difficile and Clostridium perfringens research (16 papers). Hilde Herrema is often cited by papers focused on Gut microbiota and health (43 papers), Diet and metabolism studies (23 papers) and Clostridium difficile and Clostridium perfringens research (16 papers). Hilde Herrema collaborates with scholars based in Netherlands, Sweden and United States. Hilde Herrema's co-authors include Max Nieuwdorp, Daniël H. van Raalte, Albert K. Groen, Torsten P. M. Scheithauer, Koen Wortelboer, Elena Rampanelli, Bruce A. Vallance, C. Bruce Verchere, Victor E. A. Gerdes and Abraham S. Meijnikman and has published in prestigious journals such as Cell, Journal of Biological Chemistry and Nature Medicine.

In The Last Decade

Hilde Herrema

74 papers receiving 3.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Gut Microbiota as a Trigger for Metabolic Inflammation in Obesity and Type 2 Diabetes

2020 459 citations Torsten P. M. Scheithauer, Max Nieuwdorp et al. profile →
Depicting the composition of gut microbiota in a population with varied ethnic origins but shared geography

2018 435 citations Mélanie Deschasaux, Kristien E. Bouter et al. Nature Medicine profile →

Peers

Countries citing papers authored by Hilde Herrema

Since Specialization

Citations

This map shows the geographic impact of Hilde Herrema's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hilde Herrema with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hilde Herrema more than expected).

Fields of papers citing papers by Hilde Herrema

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hilde Herrema. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hilde Herrema. The network helps show where Hilde Herrema may publish in the future.

Co-authorship network of co-authors of Hilde Herrema

This figure shows the co-authorship network connecting the top 25 collaborators of Hilde Herrema. A scholar is included among the top collaborators of Hilde Herrema based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hilde Herrema. Hilde Herrema is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Gut microbiota shift in Ghanaian individuals along the migration axis: the RODAM-Pros cohort 2025 ·Gut Microbes ·Barbara J. H. Verhaar, (unknown), (unknown), Ellis Owusu‐Dabo, (unknown), (unknown), Peter Henneman, Erik Beune, Karlijn Meeks, Max Nieuwdorp, Hilde Herrema, Bert‐Jan H. van den Born, (unknown)	0
2	Anaerobutyricum soehngenii improves glycemic control and other markers of cardio-metabolic health in adults at risk of type 2 diabetes 2025 ·Gut Microbes ·Ilias Attaye, Julia K. Bird, Max Nieuwdorp, (unknown), Jos F. M. L. Seegers, (unknown), (unknown), Hilde Herrema, Thi Phuong Nam Bui, (unknown), Willem M. de Vos	3
3	Anaerobutyricum soehngenii Reduces Hepatic Lipogenic Pathways and Increases Intestinal Gluconeogenic Gene Expression in Metabolic-Dysfunction-Associated Steatotic Liver Disease (MASLD) Mice 2024 ·International Journal of Molecular Sciences ·Anne Linde Mak, (unknown), (unknown), Stefan R. Havik, (unknown), Melany Ríos-Morales, (unknown), Joanne Verheij, Abraham S. Meijnikman, Patrick A. de Jonge, Hilde Herrema, Willem M. de Vos, Max Nieuwdorp, Aldo Grefhorst, Adriaan G. Holleboom	4
4	Maternal stress in the early postpartum period is associated with alterations in human milk microbiome composition 2024 ·Brain Behavior and Immunity ·(unknown), Rasmus Riemer Jakobsen, E.F.G. Naninck, Mark Davids, Hilde Herrema, Johannes B. van Goudoever, Susanne R. de Rooij, Anikó Kőrösi	1
5	Oral Anaerobutyricum soehngenii augments glycemic control in type 2 diabetes 2024 ·iScience ·Ilias Attaye, Julia J. Witjes, Annefleur M. Koopen, (unknown), (unknown), Koen Wortelboer, Didier Collard, E. Marleen Kemper, Maaike Winkelmeijer, Jens J. Holst, Stanley L. Hazen, Folkert Kuipers, Erik S.G. Stroes, Albert K. Groen, Willem M. de Vos, Max Nieuwdorp, Hilde Herrema	6
6	Phylogeny and disease associations of a widespread and ancient intestinal bacteriophage lineage 2024 ·Nature Communications ·Patrick A. de Jonge, Bert‐Jan H. van den Born, Aeilko H. Zwinderman, Max Nieuwdorp, Bas E. Dutilh, Hilde Herrema	5
7	Characteristics of phage-plasmids and their impact on microbial communities 2024 ·Essays in Biochemistry ·(unknown), (unknown), (unknown), Hilde Herrema, Patrick A. de Jonge, Franklin L. Nóbrega	4
8	Opportunities and challenges in phage therapy for cardiometabolic diseases 2024 ·Trends in Endocrinology and Metabolism ·Koen Wortelboer, Hilde Herrema	3
9	Anaerobic Feces Processing for Fecal Microbiota Transplantation Improves Viability of Obligate Anaerobes 2023 ·Microorganisms ·(unknown), (unknown), Koen Wortelboer, Hermie J. M. Harmsen, Mark Davids, (unknown), Marc A. Benninga, Floor Hugenholtz, Hilde Herrema, Cyriel Y. Ponsioen	16
10	Phage-microbe dynamics after sterile faecal filtrate transplantation in individuals with metabolic syndrome: a double-blind, randomised, placebo-controlled clinical trial assessing efficacy and safety 2023 ·Nature Communications ·Koen Wortelboer, Patrick A. de Jonge, Torsten P. M. Scheithauer, Ilias Attaye, E. Marleen Kemper, Max Nieuwdorp, Hilde Herrema	28
11	Challenges and costs of donor screening for fecal microbiota transplantations 2022 ·PLoS ONE ·(unknown), (unknown), (unknown), Koen Wortelboer, (unknown), (unknown), Hilde Herrema, Tom van Gool, Max Nieuwdorp, Marc A. Benninga, Cyriel Y. Ponsioen	34
12	From fecal microbiota transplantation toward next-generation beneficial microbes: The case of Anaerobutyricum soehngenii 2022 ·Frontiers in Medicine ·Koen Wortelboer, Annefleur M. Koopen, Hilde Herrema, Willem M. de Vos, Max Nieuwdorp, (unknown)	21
13	Liraglutide and sitagliptin have no effect on intestinal microbiota composition: A 12-week randomized placebo-controlled trial in adults with type 2 diabetes 2021 ·Diabetes & Metabolism ·Mark M. Smits, (unknown), Hilde Herrema, Mark Davids, Mark H.H. Kramer, Albert K. Groen, Clara Belzer, Willem M. de Vos, Djuna L. Cahen, Max Nieuwdorp, Daniël H. van Raalte	48
14	Four-and-a-half LIM domain protein 2 (FHL2) deficiency protects mice from diet-induced obesity and high FHL2 expression marks human obesity 2021 ·Metabolism ·(unknown), (unknown), Mariska Vos, Roelof Ottenhoff, Aldo Jongejan, Hilde Herrema, Noam Zelcer, Sander Kooijman, Patrick C.N. Rensen, Daniël H. van Raalte, Max Nieuwdorp, Etto C. Eringa, Carlie J.M. de Vries	18
15	Treatment with Anaerobutyricum soehngenii: a pilot study of safety and dose–response effects on glucose metabolism in human subjects with metabolic syndrome 2020 ·npj Biofilms and Microbiomes ·Pim W. Gilijamse, Annick V. Hartstra, Evgeni Levin, Koen Wortelboer, Mireille J. Serlie, Mariëtte T. Ackermans, Hilde Herrema, Aart J. Nederveen, Sultan Imangaliyev, Steven Aalvink, Morten Otto Alexander Sommer, Han Levels, Erik S.G. Stroes, Albert K. Groen, Marleen Kemper, Willem M. de Vos, Max Nieuwdorp, Andrei Prodan	77
16	Pancreatic 18F-FDG uptake is increased in type 2 diabetes patients compared to non-diabetic controls 2019 ·PLoS ONE ·Guido J. Bakker, (unknown), Torsten P. M. Scheithauer, C. Bruce Verchere, Erik S.G. Stroes, (unknown), Hilde Herrema, Max Nieuwdorp, Hein J. Verberne, Daniël H. van Raalte	5
17	Is gut microbiota a relevant and competitive dietary target for cardio-metabolic health? Proceedings of an expert workshop 2018 ·Trends in Food Science & Technology ·Elke A. Trautwein, Harry P. F. Peters, David J. Mela, Christine A. Edwards, Hilde Herrema, Jingyuan Fu, (unknown), Ruud Albers	4
18	Depicting the composition of gut microbiota in a population with varied ethnic origins but shared geography breakdown → 2018 ·Nature Medicine ·Mélanie Deschasaux, Kristien E. Bouter, Andrei Prodan, Evgeni Levin, Albert K. Groen, Hilde Herrema, Valentina Tremaroli, Guido J. Bakker, Ilias Attaye, Sara‐Joan Pinto‐Sietsma, Daniël H. van Raalte, Marieke B. Snijder, Mary Nicolaou, Ron J.G. Peters, Aeilko H. Zwinderman, Fredrik Bäckhed, Max Nieuwdorp	435
19	Gut Microbiota and Energy Expenditure in Health and Obesity 2015 ·Journal of Clinical Gastroenterology ·Guido J. Bakker, Jing Zhao, Hilde Herrema, Max Nieuwdorp	22
20	Bile Salt Sequestration Induces Hepatic De Novo Lipogenesis Through Farnesoid X Receptor– and Liver X Receptorα–Controlled Metabolic Pathways in Mice 2009 ·Hepatology ·Hilde Herrema, Maxi Meissner, Theo H. van Dijk, Gemma Brufau, Renze Boverhof, Maaike H. Oosterveer, Dirk‐Jan Reijngoud, Michael Müller, Frans Stellaard, Albert K. Groen, Folkert Kuipers	81

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact